Search
Session Type: ACR Abstract Submission ACR/ARHP Poster Session B
Sunday, November 12, 2006
2070
B-Cell Biology and Targets in Autoimmune Disease I
2074
Biology and Pathology of Bone and Joint I
2030
Clinical Osteoporosis and Metabolic Bone Disease I
2063
Crystal Arthropathies
2047
Cytokines and Mediators I
2117
Discovery 2006: Inflammatory Arthritis: Therapeutic Advances and Insights into Disease Pathogenesis
2036
Epidemiology and Health Services Research I
2068
Epidemiology: Miscellaneous
2101
Fibromyalgia and Soft Tissue Disorders I
2087
Genetics, Genomics and Proteomics I
2037
Imaging of Rheumatic Diseases I
2061
Innate Immunity and Rheumatic Disease
2028
Miscellaneous Rheumatic and Inflammatory Diseases I
2045
Osteoarthritis: Clinical Aspects I
2069
Osteoarthritis: Clinical Aspects, Risk Factors, Biomarkers and Biomechanics I
2027
Pediatric Rheumatology - Clinical and Therapeutic Aspects I
2085
Pediatric Rheumatology: New Developments in the Management of Pediatric Rheumatic Diseases
2022
RA Treatment: Small Molecules, Biologics and Gene Therapy I
2053
RA Treatment: Small Molecules, Biologics and Gene Therapy Safety
2090
RA: Animal Models I
2094
RA: Clinical
2033
RA: Clinical Aspects I
2039
RA: Human Etiology and Pathogenesis I
2079
SLE: Animal Models I
2020
SLE: Clinical Aspects and Treatment I
2059
SLE: Human Etiology and Pathogenesis I
2129
Sjögren's Syndrome I
2128
Sjögren’s Syndrome
2019
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's: Pathogenesis, Animal Models and Genetics I
2130
Systemic Sclerosis: An Update on Stem Cell Transplantation
Monday, November 13, 2006
2099
Biology and Pathology of Bone and Joint II
2086
Cytokines and Mediators I
2064
Discovery 2006: Modern Concepts of Bone Biology and Joint Pathology in Arthritis
2035
Epidemiology and Health Services Research
2023
Epidemiology and Health Services Research II
2084
Genetics, Genomics and Proteomics
2127
Infection and Vaccination in Rheumatoid Arthritis
2110
Miscellaneous Rheumatic and Inflammatory Diseases
2102
New Developments in the Pathogenesis and Management of Myositis
2048
Orthopedics, Low Back Pain and Rehabilitation
2021
RA Treatment: Small Molecules, Biologics and Gene Therapy II
2118
RA Treatment: Small Molecules, Biologics and Gene Therapy, RCTs, Remission and Progression
2075
RA: Animal Models II
2042
RA: Clinical Aspects II
2017
RA: Human Etiology and Pathogenesis II
2029
SLE: Animal Models II
2013
SLE: Clinical Aspects and Treatment II
2108
SLE: Clinical Aspects and Treatment of Cardiovascular Disease
2060
SLE: Human Etiology and Pathogenesis II
2055
Spondylarthropathies and Psoriatic Arthritis: Pathogenesis and Etiology I
2104
Spondylarthropathies and Psoriatic Arthritis: Treatment I
2032
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Skin, Lung and Quality of Life I
2111
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's Clinical Trials
2123
T-Cell Biology and Targets in Autoimmune Disease
2089
T-Regulatory Cells in Systemic Autoimmunity
2054
Vasculitis I
Tuesday, November 14, 2006
2120
Animal Models of Inflammatory Synovitis and Mechanisms of Regulation
2044
Antiphospholipid Syndrome I
2103
B-Cell Biology and Targets in Autoimmune Disease
2100
B-Cell Biology and Targets in Autoimmune Disease II
2098
Biology and Pathology of Bone and Joint II
2052
Cell, Cell Adhesion, Cell Trafficking and Angiogenesis I
2058
Clinical Osteoporosis and Metabolic Bone Disease II
2062
Current Concepts in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenesis and Treatment: Complications of Therapy
2106
Current Concepts in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenesis and Treatment: Mechanisms of Disease
2065
Cytokines and Mediators II
2131
Discovery 2006: Systemic Lupus and Scleroderma: Novel Insights into Mechanisms of Disease and Treatment
2050
Education
2038
Fibromyalgia and Soft Tissue Disorders II
2041
Genetics, Genomics and Proteomics II
2018
Imaging of Rheumatic Diseases
2078
Imaging of Rheumatic Diseases II
2091
Improving Quality Through Redesign and Innovation
2040
Improving Quality through Redesign and Innovation I
2014
Infection-Related Rheumatic Disease
2092
Innate Immunity and Rheumatic Disease
2015
Metabolic and Crystal Arthropathies
2081
Miscellaneous Rheumatic and Inflammatory Diseases II
2031
Muscle Biology, Myositis and Myopathies
2116
Orthopedics, Low Back Pain and Rehabilitation
2073
Osteoarthritis: Clinical Aspects, Risk Factors, Biomarkers and Biomechanics II
2082
Pediatric Rheumatology: Clinical and Therapeutic Aspects II
2057
Pediatric Rheumatology: Novel Insights on New and Old Pediatric Rheumatic Conditions
2026
Pediatric Rheumatology: Pathogenesis and Genetics
2043
RA Epidemiology: Impact of Disease and Treatments on Outcomes
2072
Rehabilitation Concepts in Rheumatic Disease
2016
SLE: Animal Models
2096
SLE: Human Etiology and Pathogenesis I
2112
SLE: Novel Therapies
2097
Sjögren’s Syndrome II
2119
Spondylarthropathies and Psoriatic Arthritis: Pathogenesis and Etiology
2113
Spondylarthropathies and Psoriatic Arthritis: Pathogenesis and Etiology II
2071
Spondylarthropathies and Psoriatic Arthritis: Treatment
2088
Spondylarthropathies and Psoriatic Arthritis: Treatment II
2046
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's: Pathogenesis, Animal Models and Genetics I
2121
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's: Skin, Lung and Quality of Life II
2025
T-Cell Biology and Targets in Autoimmune Disease
2051
Vasculitis II
Wednesday, November 15, 2006
2124
Clinical Significance of Autoantibodies in Rheumatoid Arthritis
2114
Fibromyalgia and Soft Tissue Disorders
2067
Osteoarthritis: Clinical Aspects II
2076
Pediatric Rheumatology: Pathogenesis and Genetics I
2093
RA Treatment: Small Molecules, Biologics and Gene Therapy New Therapies
2115
SLE: Lupus Nephritis
2109
Vasculitis II
![[Visit Client Website]](images/banner.gif)